Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Gardner-Smith assumes President and CEO role October 5, 2026.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Gardner-Smith assumes President and CEO role October 5, 2026
- Pesicka remains CEO until transition, then retires from the Board
- Pesicka consulting arrangement lasts up to 30 months for transition support
- Outstanding equity awards continue vesting during consulting term
- COBRA benefit extends Pesicka’s post-retirement compensation package
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.